107 related articles for article (PubMed ID: 20651355)
21. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
22. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
23. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
24. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
25. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells.
Ding WQ; Liu B; Vaught JL; Palmiter RD; Lind SE
Mol Cancer Ther; 2006 Jul; 5(7):1864-72. PubMed ID: 16891473
[TBL] [Abstract][Full Text] [Related]
26. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway.
Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY
Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152
[TBL] [Abstract][Full Text] [Related]
27. Anticancer activity of the antibiotic clioquinol.
Ding WQ; Liu B; Vaught JL; Yamauchi H; Lind SE
Cancer Res; 2005 Apr; 65(8):3389-95. PubMed ID: 15833873
[TBL] [Abstract][Full Text] [Related]
28. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
29. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
Fribley A; Zeng Q; Wang CY
Mol Cell Biol; 2004 Nov; 24(22):9695-704. PubMed ID: 15509775
[TBL] [Abstract][Full Text] [Related]
30. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1.
Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C
Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726
[TBL] [Abstract][Full Text] [Related]
31. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann MW; Loser P; Dietz R; von Harsdorf R
J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
[TBL] [Abstract][Full Text] [Related]
32. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death.
Schumacher M; Cerella C; Eifes S; Chateauvieux S; Morceau F; Jaspars M; Dicato M; Diederich M
Biochem Pharmacol; 2010 Feb; 79(4):610-22. PubMed ID: 19814997
[TBL] [Abstract][Full Text] [Related]
33. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Anticancer Res; 2003; 23(5A):3855-61. PubMed ID: 14666688
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
Domingo-Domènech J; Pippa R; Tápia M; Gascón P; Bachs O; Bosch M
Breast Cancer Res Treat; 2008 Nov; 112(1):53-62. PubMed ID: 18064564
[TBL] [Abstract][Full Text] [Related]
35. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.
Li X; Chen D; Yin S; Meng Y; Yang H; Landis-Piwowar KR; Li Y; Sarkar FH; Reddy GP; Dou QP; Sheng S
J Cell Physiol; 2007 Aug; 212(2):298-306. PubMed ID: 17458898
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB.
La Frazia S; Amici C; Santoro MG
Antivir Ther; 2006; 11(8):995-1004. PubMed ID: 17302369
[TBL] [Abstract][Full Text] [Related]
37. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
38. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
La Ferla-Brühl K; Westhoff MA; Karl S; Kasperczyk H; Zwacka RM; Debatin KM; Fulda S
Oncogene; 2007 Jan; 26(4):571-82. PubMed ID: 16909119
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibitor clioquinol as a candidate drug in prophylaxis and treatment of acute graft-versus-host disease.
Liang Y; Mao X; Liu H
Med Hypotheses; 2011 Mar; 76(3):400-2. PubMed ID: 21122999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
